Clinical TrialsSearch results
Number of results: 482
Recruiting
- Phase 3 study to evaluate two regimens of ianalumab on top of standard-of-care therapy in patients with systemic lupus erythematosus (SIRIUS-SLE 1)
- Systemic lupus erythematosus
- Maruyama Hideki
- 2023-02-09
Recruiting
- An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
- Pulmonary Arterial Hypertension
- Fraz Ismat
- 2023-01-30
Recruiting
- Comparison of conjunctival edema after strabismus surgery by threads
- Strabismus
- Hamasaki Ichiro
- 2023-01-30
Recruiting
- A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
- Breast Cancer
- Inoguchi Akihiro
- 2023-01-22
Recruiting
- Exploratory study to investigate the efficacy of a novel mucosal protection method for oral mucositis
- Oral mucositis
- Omori Kazuhiro
- 2023-01-19
Recruiting
- IPFAR study
- cervical cancer
- Shirakawa Shinsuke
- 2022-12-29
Completed
- A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke
- Prevention of stroke or systemic embolism of Atrial fibrillation
- Myoishi Masashi
- 2022-12-29
Other
- A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma (iinnovate-1)
- Multiple Myeloma
- Asato Takayuki
- 2022-12-26
Other
- TCD-10214
- Secondary Lymphedema
- Hayashi Shoko
- 2022-12-08
Not yet recruiting
- A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
- Newly Diagnosed Multiple Myeloma
- Lonergan Sarah
- 2022-11-25